LataMed AI Corp.
OOTC:LMEDD0.60
USD
+0.04
(+7.35%)
CIK
1477960
ISIN
US21116R4048
CUSIP
21116R404
Return %
Stock
S&P 500
1Y
633.54
14.39
3Y
-94.52
81.42
5Y
-98.66
68.62
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Kevin Rodan Levy
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- Sheridan United States
- CIK
- 0001477960
- Website
- catalystcrew.ai
- Similar Companies
- Business
- LataMed AI Corp. is a healthcare technology company that develops and deploys artificial intelligence-driven medical solutions, digital health infrastructure, and telemedicine platforms tailored for emerging markets, with an initial operational focus across Latin America. The company operates through three primary business and technological segments: Clinical Artificial Intelligence Software, Telehealth and Remote Patient Monitoring, and Industrial and Pharmacy Digital Solutions. Its core proprietary clinical AI portfolio comprises CardioAI, an artificial intelligence system for cardiovascular predictive modeling, arrhythmia detection, coronary artery disease scoring, and automated electrocardiogram (ECG) analysis; PulmoAI, a respiratory diagnostic and monitoring tool designed for chronic obstructive pulmonary disease (COPD) progression modeling, lung capacity trend analysis, pneumonia detection, and automated pulmonary function test interpretation; and NeuroAI, a neuroimaging and cognitive analytics platform designed for the early detection of neurological abnormalities, cerebrovascular risk assessment, and automated magnetic resonance imaging (MRI) and electroencephalogram (EEG) interpretation. In addition to diagnostic intelligence, the company provides integrated digital healthcare solutions, including a consumer-facing mobile healthcare application for patient onboarding, triage, and virtual consultations; remote patient monitoring (RPM) systems for chronic disease management; and specialized industrial telemedicine platforms designed for occupational healthcare delivery in remote and offshore extraction environments. In recent corporate developments, the company rebranded from Catalyst Crew Technologies Corp. to LataMed AI Corp. in April 2026 to align with its strategic transition toward healthcare artificial intelligence, followed by the execution of a 5-for-1 forward stock split in July 2026. Operationally, the company expanded its regional footprint in August 2026 by entering into a strategic commercial agreement with Droguerias Lala C.A. to implement AI-driven automation within pharmaceutical distribution and laboratory workflows, followed by a September 2026 cooperation agreement with the Venezuelan Ministry of Popular Power for Science and Technology (Mincyt) and the Ministry of Popular Power for Health (MPPS) to deploy digital triage and emergency healthcare infrastructure across the State of La Guaira. Founded in 2008, LataMed AI Corp. maintains its principal executive offices in Caracas, Venezuela, with corporate operations in Sheridan, Wyoming.